Related Experiment Video

Updated: Mar 20, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

18.3K

Comparative Effectiveness of Treatments for Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL), Using Matching

V Tongbram1, N Sengupta2, M Gaudig3

  • 1ICON Plc, Morristown, NJ, USA.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|May 21, 2016
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.7K
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

820

Related Experiment Videos

Last Updated: Mar 20, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

18.3K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.7K
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

820

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

696
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
696
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

1.2K
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
1.2K

Articles linked to this work by shared authors, journal, and citation graph.

Non-Lethal Blood Sampling of Fish in the lab and Field With Methods for Dried Blood Plasma Spot Omic Analyses.

Frontiers in genetics·2022

COVID-19 vaccination intent among London healthcare workers.

Occupational medicine (Oxford, England)·2021

The role of citizen science in addressing grand challenges in food and agriculture research.

Proceedings. Biological sciences·2018

Novel heterozygous mutations in the PGAM2 gene with negative exercise testing.

Molecular genetics and metabolism reports·2018

Removal notice to "A "cough induced" pelvic fracture as the first sign of a malignant neoplasm" [IJSCR Volume 11 (2015) 75-77].

International journal of surgery case reports·2018

Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014.

Alimentary pharmacology & therapeutics·2018

Measuring cause-specific tolerance for health inequalities using the social marginal rate of substitution.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Reasons for distributional preferences for health outcomes: A mixed method interview study.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Swimming in the Sea of Real-World Evidence (RWE) Guidance: Why More Guidance Documents Are Needed to Help Researchers Swim.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Reframing NICE's Cost-Effectiveness Threshold: Technical Benchmark or Policy Signal? A Documentary Content Analysis.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Economic evaluations of hypertension interventions in pregnancy lack standardisation: results of a systematic review.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Swimming in the Sea of RWE Guidance: Why More Guidance Will Not Help Researchers Swim.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us